These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28098164)
1. Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification. Lamoliatte F; McManus FP; Maarifi G; Chelbi-Alix MK; Thibault P Nat Commun; 2017 Jan; 8():14109. PubMed ID: 28098164 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264 [TBL] [Abstract][Full Text] [Related]
3. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4. González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136 [TBL] [Abstract][Full Text] [Related]
4. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions. Lamoliatte F; Bonneil E; Durette C; Caron-Lizotte O; Wildemann D; Zerweck J; Wenshuk H; Thibault P Mol Cell Proteomics; 2013 Sep; 12(9):2536-50. PubMed ID: 23750026 [TBL] [Abstract][Full Text] [Related]
5. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells. Hirano S; Udagawa O Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170 [TBL] [Abstract][Full Text] [Related]
6. Identification of cross talk between SUMOylation and ubiquitylation using a sequential peptide immunopurification approach. McManus FP; Lamoliatte F; Thibault P Nat Protoc; 2017 Nov; 12(11):2342-2358. PubMed ID: 29048423 [TBL] [Abstract][Full Text] [Related]
7. An arginine-rich motif of ring finger protein 4 (RNF4) oversees the recruitment and degradation of the phosphorylated and SUMOylated Krüppel-associated box domain-associated protein 1 (KAP1)/TRIM28 protein during genotoxic stress. Kuo CY; Li X; Kong XQ; Luo C; Chang CC; Chung Y; Shih HM; Li KK; Ann DK J Biol Chem; 2014 Jul; 289(30):20757-72. PubMed ID: 24907272 [TBL] [Abstract][Full Text] [Related]
8. Sumoylation as a signal for polyubiquitylation and proteasomal degradation. Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284 [TBL] [Abstract][Full Text] [Related]
9. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies. Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601 [TBL] [Abstract][Full Text] [Related]
10. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733 [TBL] [Abstract][Full Text] [Related]
12. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells. Jo S; Lee YL; Kim S; Lee H; Chung H Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546 [TBL] [Abstract][Full Text] [Related]
13. Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner. Dubuisson L; Lormières F; Fochi S; Turpin J; Pasquier A; Douceron E; Oliva A; Bazarbachi A; Lallemand-Breitenbach V; De Thé H; Journo C; Mahieux R Oncogene; 2018 May; 37(21):2806-2816. PubMed ID: 29507418 [TBL] [Abstract][Full Text] [Related]
17. Sumoylation and ubiquitylation crosstalk in the control of ΔNp63α protein stability. Ranieri M; Vivo M; De Simone M; Guerrini L; Pollice A; La Mantia G; Calabrò V Gene; 2018 Mar; 645():34-40. PubMed ID: 29246538 [TBL] [Abstract][Full Text] [Related]
18. Stability of Smyd1 in endothelial cells is controlled by PML-dependent SUMOylation upon cytokine stimulation. Becker S; Steinemann G; Karle W; Roos K; Liem CH; Muralikumar S; Volkamer A; Munz B; Zakrzewicz A; Berkholz J Biochem J; 2021 Jan; 478(1):217-234. PubMed ID: 33241844 [TBL] [Abstract][Full Text] [Related]
19. N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies. Sharma P; Murillas R; Zhang H; Kuehn MR J Cell Sci; 2010 Apr; 123(Pt 8):1227-34. PubMed ID: 20233849 [TBL] [Abstract][Full Text] [Related]
20. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]